This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Orphazyme A/s. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Gert Mads Bolwig: Innovator in Pharmaceutical Formulations
Introduction
Gert Mads Bolwig is a notable inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 2 patents, Bolwig's work has the potential to impact the medical community positively.
Latest Patents
Bolwig's latest patents include a formulation for Arimoclomol. This invention relates to a pharmaceutical formulation that provides for the extended release of an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the acid addition salts thereof. This formulation aims to enhance the therapeutic efficacy of the active ingredient.
Career Highlights
Gert Mads Bolwig is currently associated with Orphazyme A/S, a company focused on developing innovative treatments for rare diseases. His work at Orphazyme has allowed him to explore new avenues in pharmaceutical research and development.
Collaborations
Bolwig has collaborated with notable colleagues, including Anders Mørkeberg Hinsby and Thomas Kirkegaard Jensen. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Gert Mads Bolwig is a distinguished inventor whose work in pharmaceutical formulations is paving the way for new treatment options. His contributions to the field are noteworthy and reflect his commitment to innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile